Phibro Animal Health (PAHC)
(Delayed Data from NSDQ)
$17.60 USD
+0.12 (0.69%)
Updated Jul 15, 2024 04:00 PM ET
After-Market: $17.60 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth D Momentum B VGM
Brokerage Reports
0 items in cart
Phibro Animal Health Corporation [PAHC]
Reports for Purchase
Showing records 41 - 60 ( 253 total )
Company: Phibro Animal Health Corporation
Industry: Medical - Products
SGA Expense Management Drives In- Line EPS Quarter
Provider: Roth Capital Partners, Inc.
Analyst: WRIGHT B
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Hearing the Drumbeats? A Look at Past Conflicts and Their Impact on Farm Income
Provider: Roth Capital Partners, Inc.
Analyst: WRIGHT B
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department